Controls On Demand: Revolutionizing The Drug Discovery Pipeline

The evolution of treatments, such as Cell and Gene Therapy, has put a spotlight on the lack of consistent reference material for cell-based assays in the field of drug development. From discovery through to patient monitoring after commercialization, reliable controls are necessary to provide an additional layer of security.

Slingshot has developed cell mimic products which ultimately reduce the cost of therapeutic manufacturing and improve accuracy. Find out what led Slingshot leaders to tackle the consistent control blindspot in the drug development process and how they are pushing the boundaries of what a cellular mimic can do.